WeedMD has a lot going for it and is undervalued to peers on a number of important metrics - such as cash on hand, current production capacity, licensed oil sales, and domestic + international sales agreements and partnerships (such as with VIDA). HIKU had good retail exposure, and some impressive managers with retail experience, but few tangible assets and a number of cost centers - such as their retail locations in Ontario which will likely not be permitted to sell cannabis anytime soon. How do you think the HIKU buyout will affect WeedMD? Please provide a rationale for your vote in the comments.